Allakos

YTD

ALL

Why Robinhood?

You can watch Allakos and buy or sell other stocks, ETFs, and their options commission-free!

About ALLK

Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis.

CEO

Robert Alexander

CEORobert Alexander

Employees

Employees61

Headquarters

San Carlos, California

HeadquartersSan Carlos, California

Founded

2012

Founded2012

Employees

Employees61

ALLK Key Statistics

Market cap

29.74M

Market cap29.74M

Price-Earnings ratio

-0.41

Price-Earnings ratio-0.41

Dividend yield

—

Dividend yield—

Average volume

371.25K

Average volume371.25K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.56

52 Week high$1.56

52 Week low

$0.2157

52 Week low$0.2157

People also own

Based on the portfolios of people who own ALLK. This list is generated using Robinhood data, and it’s not a recommendation.